ERENUMAB-AOOE | B761077 | AMGEN INC
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | May. 17, 2030 | Active | Computed |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12434015(device) · relevance 65/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
Top 50 of 104 AI-discovered patents by relevance.
No patent or exclusivity listings for this strength.